Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04488497 · ClinicalTrials.gov registry record · NA
Cardiovascular Risk Assessment for Patients With Rheumatoid Arthritis Arthritis:
A NA study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
NCT04488497 is a NA study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 101 participants.
The verdict
NCT04488497, a NA study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
Study Summary
One of the greatest success stories in rheumatology - the achievement of rheumatoid arthritis (RA) remission - is tempered by the fact that individuals with RA are dramatically under evaluated and under treated to reduce the risk for heart attacks and strokes. This project will build the foundation for an intervention that will test the hypothesis that the patient-centered intervention tailored to patients with RA to improve hyperlipidemia screening and treatment, thereby decreasing the risk for heart attacks and strokes. The aims of this proposal are: Aim 1: To identify patient and physician barriers to lower the risk for heart attacks and strokes in patients with RA. Aim 2: To develop an intervention designed to optimize lipid screening and management in RA patients. This will consist of patient education and a decision support program to facilitate screening for hyperlipidemia (high cholesterol level) or initiation of medications to lower cholesterol (primary outcome) and self-efficacy (level of confidence in performing a task) in taking medications to lower cholesterol secondary outcome). Aim 3: To pilot test the efficacy and feasibility of intervention developed in Aim 2. The investigators will apply methods related to clinical trials to test the feasibility of the newly developed intervention.
Interventions
- BEHAVIORAL Standard of care
- BEHAVIORAL Cardiovascular Risk Assessment for Patients with Rheumatoid Arthritis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2021-01-27 |
| Est. Completion | 2024-11-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04488497
The ClinicalTrials.gov registry entry for NCT04488497 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of care is the first listed.
NCT04488497 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04488497 about?
NCT04488497 is a clinical study titled "Cardiovascular Risk Assessment for Patients With Rheumatoid Arthritis Arthritis:". One of the greatest success stories in rheumatology - the achievement of rheumatoid arthritis (RA) remission - is tempered by the fact that individuals with RA are dramatically under evaluated and under treated to reduce the risk for heart attacks and strokes. This project will build the foundation ...
What is the current status of trial NCT04488497?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2021-01-27. Estimated completion is 2024-11-06.
What interventions are being tested in trial NCT04488497?
The interventions under investigation include: Standard of care (BEHAVIORAL), Cardiovascular Risk Assessment for Patients with Rheumatoid Arthritis (BEHAVIORAL).
Who is sponsoring clinical trial NCT04488497?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.